[Federal Register Volume 66, Number 201 (Wednesday, October 17, 2001)]
[Notices]
[Pages 52781-52782]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26014]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 4, 2000, and published in the Federal 
Register on January 10, 2001, (66 FR 2003), Chiragene, Inc., Technology 
Center of New Jersey, 661 Highway One, North Brunswick, New Jersey 
08902, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)..................  I
2, 5-Dimethoxyamphetamine (7396)...........  I
3, 4-Methylenedioxyamphetamine (7400)......  I
4-Methoxyamphetamine (7411)................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
supply their customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Chiragene, Inc. to

[[Page 52782]]

manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Chiragene, Inc. on a 
regular basis to ensure that the company's continued registration is 
consistent with the public interest. These investigations have included 
inspection and testing of the company's physical security systems, 
audits of the company's records, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic classes 
of controlled substances listed above is granted.

    Dated: October 5, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-26014 Filed 10-16-01; 8:45 am]
BILLING CODE 4410-09-M